...
vcel-img

Vericel Corp Ord, Common Stock

VCEL

NMQ

$56.321

-$0.37

(-0.65%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.79B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
705.75
Volume info-icon
This is the total number of shares traded during the most recent trading day.
369.83K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.67
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$32.31 L
$61.49 H
$56.321

About Vericel Corp Ord, Common Stock

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameVCELSectorS&P500
1-Week Return-1.51%-3.39%0.2%
1-Month Return7.18%-1.92%2.72%
3-Month Return27.91%-10.54%7.31%
6-Month Return35.91%-4.47%10.44%
1-Year Return65.37%4.06%27.53%
3-Year Return38.88%0.94%30.88%
5-Year Return223.76%36.67%89.21%
10-Year Return1871.83%102.87%199.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue117.85M124.18M156.18M164.37M197.52M[{"date":"2019-12-31","value":59.67,"profit":true},{"date":"2020-12-31","value":62.87,"profit":true},{"date":"2021-12-31","value":79.07,"profit":true},{"date":"2022-12-31","value":83.22,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue37.57M39.95M50.16M54.58M61.94M[{"date":"2019-12-31","value":60.66,"profit":true},{"date":"2020-12-31","value":64.5,"profit":true},{"date":"2021-12-31","value":80.98,"profit":true},{"date":"2022-12-31","value":88.11,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit80.28M84.23M106.03M109.79M135.58M[{"date":"2019-12-31","value":59.21,"profit":true},{"date":"2020-12-31","value":62.13,"profit":true},{"date":"2021-12-31","value":78.2,"profit":true},{"date":"2022-12-31","value":80.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin68.12%67.83%67.88%66.80%68.64%[{"date":"2019-12-31","value":99.24,"profit":true},{"date":"2020-12-31","value":98.82,"profit":true},{"date":"2021-12-31","value":98.9,"profit":true},{"date":"2022-12-31","value":97.31,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses91.53M81.86M113.88M126.85M142.04M[{"date":"2019-12-31","value":64.44,"profit":true},{"date":"2020-12-31","value":57.63,"profit":true},{"date":"2021-12-31","value":80.17,"profit":true},{"date":"2022-12-31","value":89.3,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(11.25M)667.00K(7.85M)(17.06M)(6.46M)[{"date":"2019-12-31","value":-1686.81,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1177.51,"profit":false},{"date":"2022-12-31","value":-2557.42,"profit":false},{"date":"2023-12-31","value":-969.12,"profit":false}]
Total Non-Operating Income/Expense3.19M1.36M492.00K2.04M7.39M[{"date":"2019-12-31","value":43.21,"profit":true},{"date":"2020-12-31","value":18.37,"profit":true},{"date":"2021-12-31","value":6.66,"profit":true},{"date":"2022-12-31","value":27.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(9.66M)3.04M(7.58M)(15.99M)(2.37M)[{"date":"2019-12-31","value":-317.51,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-249.08,"profit":false},{"date":"2022-12-31","value":-525.23,"profit":false},{"date":"2023-12-31","value":-77.79,"profit":false}]
Income Taxes(1.76M)180.00K(111.00K)721.00K814.00K[{"date":"2019-12-31","value":-215.72,"profit":false},{"date":"2020-12-31","value":22.11,"profit":true},{"date":"2021-12-31","value":-13.64,"profit":false},{"date":"2022-12-31","value":88.57,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(7.91M)2.86M(7.47M)(16.71M)(3.18M)[{"date":"2019-12-31","value":-276.15,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-260.86,"profit":false},{"date":"2022-12-31","value":-583.41,"profit":false},{"date":"2023-12-31","value":-111.1,"profit":false}]
Income From Continuous Operations(9.66M)2.86M(7.47M)(16.71M)(10.25M)[{"date":"2019-12-31","value":-337.47,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-260.86,"profit":false},{"date":"2022-12-31","value":-583.41,"profit":false},{"date":"2023-12-31","value":-358,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(7.91M)2.86M(7.47M)(16.71M)(3.18M)[{"date":"2019-12-31","value":-276.15,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-260.86,"profit":false},{"date":"2022-12-31","value":-583.41,"profit":false},{"date":"2023-12-31","value":-111.1,"profit":false}]
EPS (Diluted)0.150.05(0.17)(0.36)(0.09)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":33.33,"profit":true},{"date":"2021-12-31","value":-113.33,"profit":false},{"date":"2022-12-31","value":-240,"profit":false},{"date":"2023-12-31","value":-60,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

VCEL
Cash Ratio 2.46
Current Ratio 4.61
Quick Ratio 4.23

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VCEL
ROA (LTM) -0.22%
ROE (LTM) 1.54%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VCEL
Debt Ratio Lower is generally better. Negative is bad. 0.34
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.66

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VCEL
Trailing PE 705.75
Forward PE 106.38
P/S (TTM) 12.29
P/B 10.82
Price/FCF NM
EV/R 12.27
EV/Ebitda 266.52
PEG NM

FAQs

What is Vericel Corp Ord share price today?

Vericel Corp Ord (VCEL) share price today is $56.321

Can Indians buy Vericel Corp Ord shares?

Yes, Indians can buy shares of Vericel Corp Ord (VCEL) on Vested. To buy Vericel Corp Ord from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VCEL stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Vericel Corp Ord be purchased?

Yes, you can purchase fractional shares of Vericel Corp Ord (VCEL) via the Vested app. You can start investing in Vericel Corp Ord (VCEL) with a minimum investment of $1.

How to invest in Vericel Corp Ord shares from India?

You can invest in shares of Vericel Corp Ord (VCEL) via Vested in three simple steps:

  • Click on Sign Up or Invest in VCEL stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Vericel Corp Ord shares
What is Vericel Corp Ord 52-week high and low stock price?

The 52-week high price of Vericel Corp Ord (VCEL) is $61.49. The 52-week low price of Vericel Corp Ord (VCEL) is $32.31.

What is Vericel Corp Ord price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Vericel Corp Ord (VCEL) is 705.75

What is Vericel Corp Ord price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Vericel Corp Ord (VCEL) is 10.82

What is Vericel Corp Ord dividend yield?

The dividend yield of Vericel Corp Ord (VCEL) is 0.00%

What is the Market Cap of Vericel Corp Ord?

The market capitalization of Vericel Corp Ord (VCEL) is $2.79B

What is Vericel Corp Ord’s stock symbol?

The stock symbol (or ticker) of Vericel Corp Ord is VCEL

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top